A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.


Updates from The Motley Fool

Latest updates on Sinovac Biotech from Fool.com.
This Week in Biotech

A look back at the biggest stories this week in biotech and what they mean for investors.



Stock Performance

View Interactive SVA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Sinovac Biotech.
Current Price: $7.02
Prev Close: $7.04
Open: $7.01
Bid: $6.88
Ask: $7.68
Day's Range: $7.01 - $7.04
52wk Range: $4.60 - $7.16
Volume: 13,983
Avg Vol 85,244
Market Cap: $400M
P/E (ttm): -58.67
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Sinovac Biotech.
CAPS Rating 1 out of 5
 
357 Outperform
29 Underperform
CAPS All Stars
 
43 Outperform
13 Underperform

How do you think Sinovac Biotech will perform against the market?



You pick for Sinovac Biotech is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Weidong Yin, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Sinovac Biotech.

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers